AbbVie
ABBV
ABBV
3,345 hedge funds and large institutions have $217B invested in AbbVie in 2024 Q2 according to their latest regulatory filings, with 153 funds opening new positions, 1,460 increasing their positions, 1,310 reducing their positions, and 123 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% less funds holding
Funds holding: 3,361 → 3,345 (-16)
5% less capital invested
Capital invested by funds: $228B → $217B (-$11.1B)
21% less funds holding in top 10
Funds holding in top 10: 222 → 176 (-46)
Holders
3,345
Holding in Top 10
176
Calls
$2.77B
Puts
$2.09B
Top Buyers
| 1 | +$1.01B | |
| 2 | +$825M | |
| 3 | +$517M | |
| 4 |
Goldman Sachs
New York
|
+$467M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$387M |
Top Sellers
| 1 | -$1.63B | |
| 2 | -$1.12B | |
| 3 | -$395M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$169M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$139M |